An International Survey on the pragmatic management of epistaxis

An International Survey on the pragmatic management of epistaxis


  • Desiderio Passali International Federation ORL Societies (IFOS)
  • Valerio Damiani DMG Medical Department, Pomezia (Rome), Italy
  • Francesco Maria Passali ENT Department, University Tor Vergata, Rome, Italy 
  • Maria Angela Tosca Pediatric Allergy Center, Istituto G. Gaslini, Genoa, Italy
  • Gaetano Motta ENT Department, Univerisity Luigi Vanvitelli, Naples, Italy
  • Giorgio Ciprandi Allergy Clinic, Casa di Cura Villa Montallegro, Genoa, Italy


epistaxis, otorhinolaryngology, emergency, medical treatment, surgery


Epistaxis is one of the most common ear, nose and throat emergencies. The management of epistaxis has evolved significantly in recent years, including the use of nasal cautery and packs. However, a correct treatment requires the knowledge of nasal anatomy, potential risks, and complications of treatment. Epistaxis is often a simple and readily treatable condition, even though a significant bleed may have potentially severe consequences. At present, there are very few guidelines concerning this topic. The current Survey explored the pragmatic approach in managing epistaxis. A questionnaire, including 7 practical questions has been used. The current International Survey on epistaxis management reported a relevant prevalence (21.7%), mainly during childhood and senescence, an important hospitalization rate (11.8%), the common use of anterior packing and electrocoagulation, and the popular prescription of a vitamin supplement and intranasal creams.


1) Yau S. An update on epistaxis. Aust Fam Physician. 2015;44:653-6
2) Leong SC, Roe RJ, Karkanevatos A. No frills management of epistaxis. Emerg Med J. 2005 Jul;22(7):470-2
3) Iqbal IZ, Jones GH, Dawe N, Mamais C, Smith ME, Williams RJ, et al. Intranasal packs and haemostatic agents for the management of adult epistaxis: systematic review. J Laryngol Otol. 2017;131:1065-1092
4) Morgan DJ, Kellerman R. Epistaxis: evaluation and treatment. Prim Care Clin Office Pract 2014;41:63-73
5) Kravchilk L, Pester JM. Anterior epistaxis nasal pack. StatPearls April 2019
6) Meccariello G, Georgalas C, Montevecchi F, Cammaroto G, Gobbi R, Firinu E, et al. Management of idiopathic epistaxis in adults: what's new? Acta Otorhinolaryngol Ital 2019 (in press)
7) Min HJ, Kang H, Choi GJ, Kim KS. Association between Hypertension and Epistaxis: Systematic Review and Meta-analysis. Otolaryngol Head Neck Surg. 2017;157:921-927
8) Diamond L. Managing epistaxis. JAAPA 2014;27: 35–9
9) Kamhieh Y, Fox H. Tranexamic acid in epistaxis: a systematic review. Clin Otolaryngol. 2016;41:771-776
10) Musgrave KM, Powell J. A systematic review of anti-thrombotic therapy in epistaxis. Rhinology. 2016;54:292-391
11) Iqbal IZ, Jones GH, Dawe N, Mamais C, Smith ME, Williams RJ, et al. Intranasal packs and haemostatic agents for the management of adult epistaxis: systematic review. J Laryngol Otol. 2017;131
12) National ENT Trainee Research Network. The British Rhinological Society multidisciplinary consensus recommendations on the hospital management of epistaxis. J Laryngol Otol. 2017;131:1142-1156
13) Verillaud B, Robard L, Michel J, Priliere Escabase V, Bequignon E, Crampette L, et al. Guidelines of the French Society of Otorhinolaryngology (SFORL). Second-line treatment of epistaxis in adults. Eur Ann Otorhinolaryng 2017;134:191-3
14) Beck R, Sorge M, Schneider A, Dietz A. Current Approaches to Epistaxis Treatment in Primary and Secondary Care. Dtsch Arztebl Int 2018;115:12-22
15) Passali D and Gruppo di Studio “Epistassi”. Haemostatic ointment efficacy in the treatment and prevention of epistaxis: a multicentric study in 100 patients. Clin Ter 2005;156:3-7




How to Cite

Passali D, Damiani V, Passali FM, Tosca MA, Motta G, Ciprandi G. An International Survey on the pragmatic management of epistaxis. Acta Biomed [Internet]. 2020 Feb. 17 [cited 2024 Jul. 16];91(1-S):5-10. Available from: